UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial

Annals of oncology, 2018-08, Vol.29 (8), p.1763-1770

2018

Link zum Volltext

Verfügbarkeit prüfen

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

British journal of cancer, 2010-01, Vol.102 (1), p.68-72

2010

Link zum Volltext

Verfügbarkeit prüfen

Everolimus plus aromatase inhibitors vs aromatase inhibitors as maintenance therapy after first-line chemotherapy in HR+/HER2- metastatic breast cancer: Final results of the phase III randomized MAIN-A trial

Annals of oncology, 2019-05, Vol.30, p.iii73-iii73

2019

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer

Annals of oncology, 2009-03, Vol.20 (3), p.469-474

2009

Link zum Volltext

Verfügbarkeit prüfen

Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy

British journal of cancer, 2010-09, Vol.103 (7), p.1019-1024

2010

Link zum Volltext

Verfügbarkeit prüfen

High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study

Annals of oncology, 2015-01, Vol.26 (1), p.167-172

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry

Bone marrow transplantation (Basingstoke), 2013-03, Vol.48 (3), p.414-418

2013

Link zum Volltext

Verfügbarkeit prüfen

Oropharyngeal squamous cell carcinoma and HPV. Systematic review on overall management

Journal of stomatology, oral and maxillofacial surgery, 2017-04, Vol.118 (2), p.103-108

2017

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

Annals of oncology, 2006-07, Vol.17 (7), p.1134-1140

2006

Link zum Volltext

Verfügbarkeit prüfen

Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma

British journal of cancer, 2005-07, Vol.93 (1), p.35-40

2005

Link zum Volltext

Verfügbarkeit prüfen

EE362 A Budget Impact Analysis of Pertuzumab, Trastuzumab, and Chemotherapy in the Neoadjuvant Setting for HER2-Positive High-Risk Early Breast Cancer Patients: Insights from the Tuscany Regional Health Care System Perspective

Value in health, 2023-12, Vol.26 (12), p.S121

2023

Link zum Volltext

Verfügbarkeit prüfen

Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study

British journal of cancer, 2006-04, Vol.94 (7), p.1016-1020

2006

Link zum Volltext

Verfügbarkeit prüfen

High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trial

Annals of oncology, 2005-05, Vol.16 (5), p.726-734

2005

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme

BJU international, 2019-01, Vol.123 (1), p.98-105

2019

Link zum Volltext

Verfügbarkeit prüfen

C8 INSTITUTIONAL VALIDATION OF THE JOINT ANMCO AND AIOM TUSCANY CLINICAL CARDIO–ONCOLOGY PATHWAY FOR THE CARDIOLOGY MANAGEMENT OF CANCER OUTPATIENTS

European heart journal supplements, 2023-05, Vol.25 (Supplement_D), p.D3-D3

2023

Link zum Volltext

Verfügbarkeit prüfen

Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas

Journal of clinical oncology, 1993-04, Vol.11 (4), p.720-725

1993

Link zum Volltext

Verfügbarkeit prüfen

HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support

Bone marrow transplantation (Basingstoke), 2004-09, Vol.34 (5), p.413-417

2004

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-15-03: nab -paclitaxel + carboplatin or gemcitabine vs gemcitabine/carboplatin as first-line treatment for patients with triple-negative metastatic breast cancer: Results from the randomized phase 2 portion of the tnAcity trial

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P5-P5-15-03

2017

Link zum Volltext

Verfügbarkeit prüfen

7100 High-dose sequential chemotherapy versus conventional-dose chemotherapy as first-line treatment for advanced poor prognosis germ-cell tumors: a multicenter Phase III Italian trial

European journal of cancer supplements, 2009, Vol.7 (2), p.422-422

2009

Link zum Volltext

Verfügbarkeit prüfen

Italian nivolumab expanded access programme in non-squamous non-small cell lung cancer patients: Real-world results in never smokers and EGFR positive patients

Annals of oncology, 2017-09, Vol.28, p.v470-v471

2017

Link zum Volltext

Verfügbarkeit prüfen

P1.15-01 Radiotherapy (RT) and Nivolumab in Non-Small-Cell Lung Cancer (NSCLC): A Multicenter Real-Life Experience

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S611-S611

2018

Link zum Volltext

Verfügbarkeit prüfen

Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses

Journal of clinical oncology, 1995-05, Vol.13 (5), p.1160-1166

1995

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of thrombopoiesis kinetics by measurement of reticulated platelets and CD34(+) cell subsets in patients with solid tumors following high dose chemotherapy and autologous peripheral blood progenitor cell support

Haematologica (Roma), 2001-09, Vol.86 (9), p.959

2001

Link zum Volltext

Verfügbarkeit prüfen

MA 11.11 Italian Nivolumab Expanded Access Program in Non-Squamous NSCLC Patients: Results in Never Smokers and EGFR Positive Patients

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1847-S1847

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(73)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(39)
Humans
(36)
Female
(30)
Oncology
(27)
Adult
(26)
Biological And Medical Sciences
(26)
Middle Aged
(26)
Medical Sciences
(24)
Aged
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(16)
Pharmacology. Drug Treatments
(13)
Antineoplastic Agents
(12)
Breast Neoplasms - Drug Therapy
(12)
Chemotherapy
(11)
Disease-Free Survival
(11)
Male
(10)
Treatment Outcome
(10)
Tumors
(10)
Hematopoietic Stem Cell Transplantation
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial

Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

Everolimus plus aromatase inhibitors vs aromatase inhibitors as maintenance therapy after first-line chemotherapy in HR+/HER2- metastatic breast cancer: Final results of the phase III randomized MAIN-A trial

Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer

Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy

High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study

Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry

Oropharyngeal squamous cell carcinoma and HPV. Systematic review on overall management

Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma

EE362 A Budget Impact Analysis of Pertuzumab, Trastuzumab, and Chemotherapy in the Neoadjuvant Setting for HER2-Positive High-Risk Early Breast Cancer Patients: Insights from the Tuscany Regional Health Care System Perspective

Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study

High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trial

216MO A randomized phase II trial of metronomic oral vinorelbine plus cyclophosphamide and capecitabine (VEX) vs weekly paclitaxel (P) as first- or second-line treatment in patients (pts) with ER+/HER2- metastatic breast cancer (MBC): The METEORA-II trial (IBCSG 54-16)

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real‐world results from an expanded access programme

C8 INSTITUTIONAL VALIDATION OF THE JOINT ANMCO AND AIOM TUSCANY CLINICAL CARDIO–ONCOLOGY PATHWAY FOR THE CARDIOLOGY MANAGEMENT OF CANCER OUTPATIENTS

Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas

HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support

Abstract P5-15-03: nab -paclitaxel + carboplatin or gemcitabine vs gemcitabine/carboplatin as first-line treatment for patients with triple-negative metastatic breast cancer: Results from the randomized phase 2 portion of the tnAcity trial

7100 High-dose sequential chemotherapy versus conventional-dose chemotherapy as first-line treatment for advanced poor prognosis germ-cell tumors: a multicenter Phase III Italian trial

Italian nivolumab expanded access programme in non-squamous non-small cell lung cancer patients: Real-world results in never smokers and EGFR positive patients

P1.15-01 Radiotherapy (RT) and Nivolumab in Non-Small-Cell Lung Cancer (NSCLC): A Multicenter Real-Life Experience

Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses

Evaluation of thrombopoiesis kinetics by measurement of reticulated platelets and CD34(+) cell subsets in patients with solid tumors following high dose chemotherapy and autologous peripheral blood progenitor cell support

MA 11.11 Italian Nivolumab Expanded Access Program in Non-Squamous NSCLC Patients: Results in Never Smokers and EGFR Positive Patients

Suchergebnisse filtern